Sarcosine oxidase (EC 1.5.3.1) produced by Bacillus sp. B-0618 was purified by ion exchange chromatography on diethyl aminoethyl-cellulose and gel filtration on Sephadex G-100 and G-150. The molecular weight of the enzyme was estimated to be 42000 by gel filtration on Sephadex G-150 and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The enzyme exhibited an absorption spectrum characteristic of flavoprotein. The enzyme showed the maximum activity at pH 8.5-9 and was stable at pH 7-10. The pI value was 4.7 as determined by isoelectric focusing . Although sarcosine is the preferred substrate, the enzyme also oxidized N-methyl-DL-alanine, N-methyl-Lleucine and N-methyl-DL-valine to lesser extents. The apparent Km values of sarcosine, N-methyl-DL-alanine, N-methyl-L-leucine and N-methyl-DL-valine were 12.2, 6.8, 106 and 173 mM, respectively. The enzyme was inactivated by N-bromosuccinimide, Zn2+ , Fe3 + and Hg2+ , but not by -ethylenediaminetetraacetate , p-chloromercuribenzoate, monoiodoacetate or p-toluenesulfonylchloride.
Sarcosine oxidase (EC 1.5.3.1) produced by Bacillus sp. B-0618 was purified by ion exchange chromatography on diethyl aminoethyl-cellulose and gel filtration on Sephadex G-100 and G-150. The molecular weight of the enzyme was estimated to be 42000 by gel filtration on Sephadex G-150 and sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The enzyme exhibited an absorption spectrum characteristic of flavoprotein. The enzyme showed the maximum activity at pH 8.5-9 and was stable at pH 7-10. The pI value was 4.7 as determined by isoelectric focusing . Although sarcosine is the preferred substrate, the enzyme also oxidized N-methyl-DL-alanine, N-methyl-Lleucine and N-methyl-DL-valine to lesser extents. The apparent Km values of sarcosine, N-methyl-DL-alanine, N-methyl-L-leucine and N-methyl-DL-valine were 12.2, 6.8, 106 and 173 mM, respectively. The enzyme was inactivated by N-bromosuccinimide, Zn2+ , Fe3 + and Hg2+ , but not by -ethylenediaminetetraacetate , p-chloromercuribenzoate, monoiodoacetate or p-toluenesulfonylchloride.
Keywords
. sarcosine oxidase (EC 1.5.3.1); sarcosine; Bacillus; clinical diagnosis; flavoprotein The Folin method1) is most commonly used in the clinical diagnostic analysis of creatinine in serum and urine. However, this method has the disadvantages of poor specificity and requirement for deproteinization. This is the reason why enzymatic measurement systems2-5) are gradually replacing the Folin method. Some of the enzymatic systems consist of creatinine amidohydrolase (creatininase, EC 3.5.2.10), creatine amidinohydrolase (creatinase, EC 3.5.3.3) and sarcosine oxidase (EC 1.5.3.1). The first one catalyzes interconversion between creatinine and creatine, the second hydrolyzes creatine to sarcosine and urea and the last further hydrolyzes sarcosine to glycine and formaldehyde, generating hydrogen peroxide. Formaldehyde can be determined by using formaldehyde dehydrogenase, on one hand, and peroxidase can be conveniently used for the determination of hydrogen peroxide, on the other hand.
We have already reported the purification and characterization of creatininase and creatinase of Alkaligenes origin.6,7) Recently, we observed the high yield production of sarcosine oxidase by strain B-0618. As mentioned above, the enzyme might complement two other creatinine-catabolic enzymes, creatininase and creatinase, in the determination of creatinine and/or creatine in clinical samples. The details of the purification and characterization of sarcosine oxidase produced by strain B-0618 and the taxonomy of the producing organism are presented in this paper. The enzyme (75 pg as protein) was subjected to electrophoresis at a constant current of 10 mA per gel for 4 h, and then the gel was stained with 0 .25% Coomassie Brilliant Blue R-250. 
Prosthetic Groups of Sarcosine Oxidase
The enzyme showed a characteristic absorption spectrum of flavoprotein with absorption maxima at 276, 360 and 453 nm ( Fig. 2A) . When sarcosine was added to the enzyme solution under anaerobic conditions, the peaks at 360 and 453 nm disappeared (Fig . 2B) . The enzyme solution was kept in a boiling water bath for 5 min in the presence of 10% trichloroacetic acid . The supernatant obtained by centrifugation did not contain any colored material . However, the enzyme digested by pronase released a yellowish material in the supernatant . The absorption spectrum shows peaks at 333 and 450 nm (Fig . 2C) , suggesting the existence of covalently bound flavin.
Estimation of Molecular Weight
By both SDS-polyacrylamide gel electrophoresis and gel filtration on Sephadex G-150 , the molecular weight of the enzyme was estimated to be 42000 .
Isoelectric Point of Sarcosine Oxidase
The pI value was determined to be 4.7 by isoelectric focusing .
Effects of pH on Sarcosine Oxidase Activity and Stability
The effects of pH on the enzyme activity and stability were tested by assay method I . The optimum activity was observed at pH 8.5-9. Although the enzyme was stable at pH 7-10 , it seemed especially labile at pH below 5.
Effects of Various Chemicals and Metal Ions
The sarcosine oxidase activity was measured by assay method I . The enzyme was inactivated by N-bromosuccinimide, Zn2 , Fe' , and He , but not by p-chloromercuribenzoate (PCMB), EDTA or p-toluenesulfonylchloride (Tables VI and VII) .
Substrate Specificity and Kinetics
The relative rates of the oxidation of various substrates by the enzyme were measured by assay method II. The enzyme was active toward sarcosine , N-methyl-DL-alanine, N-methyl-DL-valine and N-methyl-L-leucine, but completely inactive toward amino acids , fi-alanine, Nmethylethanolamine, N,N-dimethylethanolamine, choline, betaine , N-methylhydantoin, 2-methylalanine, 1,3-dimethylurea, 1-methylguanidine, methoxyacetate, creatine and creatinine. The apparent K. and relative Vmax values of N-methylamino acids were estimated from Lineweaver-Burk plots15) and the results are shown in Table VIII . The Km and relative Vmax values were calculated by assay method I, using a reaction mixture composed of 0.9 ml substrate solution (10-300 mm) in 0.1 M Tris-HCl buffer (pH 8.5) and 0.1 ml of aqueous enzyme solution (0.5, 2.0, 1.5 or 1.5 unit/ml).
Discussion
To date, sarcosine oxidase from Corynebacterium sp. U-9616) and Cylindrocarpon didymum M-1 1 7) have been reported. The former was found to have a molecular weight of 174000 and be composed of four non-identical subunits, and the latter was reported to be a monomer with a molecular weight of 45000. Both enzymes were inactivated by PCMB and monoiodoacetate. However, sarcosine oxidase from strain B-0618 is a monomer with a molecular weight of 42000 and is not inactivated by PCMB, monoiodoacetate or Nethylmaleimide. Further, the K. values of the enzymes from Corynebacterium, Cylindrocarpon and strain B-0618 for sarcosine were 3.4, 1.8 and 12.2 mm, respectively, and the corresponding specific activities were 8.93, 27.6 and 35.8 units/mg protein.
Sarcosine oxidase from strain B-0618 was active toward N-methyl-DL.-alanine, Nmethyl-L-leucine and N-methyl-DL-valine as well as sarcosine. On polyacrylamide gel electrophoresis, the mobilities of the diformazan band which showed the position of enzyme activity were identical for all above-mentioned substrates. Further, the diformazan band had the same mobility as the major protein band. This implies that the oxidation of sarcosine, Nmethyl-DL-alanine, N-methyl-L-leucine, N-methyl-DL-valine is catalyzed by the same component, although the enzyme preparation still contained a trace amount of minor components.
It was reported that N-methyl-L-amino acid oxidase (EC 1.5.3.2) of rabbit kidney catalyzed the oxidation of N-methyl-L-amino acid to formaldehyde and L-amino acid, generating hydrogen peroxide with consumption of oxygen, but is not active toward sarcosine.18) In this respect, sarcosine oxidase of strain B-0618 is distinguished from Nmethyl-t-amino acid oxidase of rabbit kidney.
The sarcosine oxidase of Bacillus origin should be useful in the enzymatic determination of creatinine and/or creatine in clinical samples in combination with creatininase and/or creatinase, and a study aimed at the clinical application of the enzymes is in progress in our laboratory.
